2-219435029-C-T

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_005876.5(SPEG):​c.52C>T​(p.Pro18Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000293 in 1,500,184 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P18P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00030 ( 1 hom. )

Consequence

SPEG
NM_005876.5 missense

Scores

1
5
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 0.873
Variant links:
Genes affected
SPEG (HGNC:16901): (striated muscle enriched protein kinase) This gene encodes a protein with similarity to members of the myosin light chain kinase family. This protein family is required for myocyte cytoskeletal development. Along with the desmin gene, expression of this gene may be controlled by the desmin locus control region. Mutations in this gene are associated with centronuclear myopathy 5. [provided by RefSeq, Jun 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06571835).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000223 (34/152208) while in subpopulation AMR AF= 0.000392 (6/15306). AF 95% confidence interval is 0.00023. There are 0 homozygotes in gnomad4. There are 19 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SPEGNM_005876.5 linkuse as main transcriptc.52C>T p.Pro18Ser missense_variant 1/41 ENST00000312358.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SPEGENST00000312358.12 linkuse as main transcriptc.52C>T p.Pro18Ser missense_variant 1/415 NM_005876.5 P1Q15772-5

Frequencies

GnomAD3 genomes
AF:
0.000224
AC:
34
AN:
152098
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.0000960
AC:
9
AN:
93706
Hom.:
0
AF XY:
0.000113
AC XY:
6
AN XY:
52988
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000196
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000152
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000301
AC:
406
AN:
1347976
Hom.:
1
Cov.:
31
AF XY:
0.000280
AC XY:
186
AN XY:
665022
show subpopulations
Gnomad4 AFR exome
AF:
0.0000365
Gnomad4 AMR exome
AF:
0.000187
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000329
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000358
Gnomad4 OTH exome
AF:
0.000302
GnomAD4 genome
AF:
0.000223
AC:
34
AN:
152208
Hom.:
0
Cov.:
33
AF XY:
0.000255
AC XY:
19
AN XY:
74426
show subpopulations
Gnomad4 AFR
AF:
0.0000722
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.000338
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.000347
Hom.:
0
Bravo
AF:
0.000261
ExAC
AF:
0.0000246
AC:
2
Asia WGS
AF:
0.000289
AC:
1
AN:
3474

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Myopathy, centronuclear, 5 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityMay 10, 2023- -
not specified Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingGenetic Services Laboratory, University of ChicagoJun 27, 2022DNA sequence analysis of the SPEG gene demonstrated a sequence change, c.52C>T, in exon 1 that results in an amino acid change, p.Pro18Ser. This sequence change has been described in the gnomAD database with a frequency of 0.023% in the non-Finnish European subpopulation (dbSNP rs544959269). The p.Pro18Ser change affects a moderately conserved amino acid residue located in a domain of the SPEG protein that is not known to be functional. The p.Pro18Ser substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This sequence change does not appear to have been previously described in individuals with SPEG-related disorders. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Pro18Ser change remains unknown at this time. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 07, 2021The c.52C>T (p.P18S) alteration is located in exon 1 (coding exon 1) of the SPEG gene. This alteration results from a C to T substitution at nucleotide position 52, causing the proline (P) at amino acid position 18 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 13, 2022This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 18 of the SPEG protein (p.Pro18Ser). This variant is present in population databases (rs544959269, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SPEG-related conditions. ClinVar contains an entry for this variant (Variation ID: 1432832). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.021
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.57
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.066
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
0.97
L
MutationTaster
Benign
0.98
D
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-2.5
D
REVEL
Benign
0.12
Sift
Uncertain
0.019
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.38
B
Vest4
0.17
MutPred
0.29
Gain of phosphorylation at P18 (P = 0.005);
MVP
0.56
MPC
0.65
ClinPred
0.099
T
GERP RS
4.0
Varity_R
0.16
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs544959269; hg19: chr2-220299751; API